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Abstract 
Worldwide, congenital anomalies are a leading cause of fetal death, infant mortality and 
morbidity in childhood. Of the 5.2 million births in the European Union (EU) each year, 
approximately 104,000 (2.5%) will be born with congenital anomalies. EUROCAT is a 
European network of population-based registries whose objectives are to provide essential 
epidemiologic information on congenital anomalies in Europe, to facilitate the early warning 
of new teratogenic exposures and to evaluate the effectiveness of primary prevention.  
Each year, EUROCAT performs statistical monitoring for both trends and clusters in time on 
82 anomaly subgroups. Statistical monitoring relates to two of EUROCAT’s objectives: to 
provide essential epidemiologic information on congenital anomalies in Europe and to co-
ordinate the detection of, and response to, clusters and early warning of teratogenic 
exposures. The results of the statistical monitoring are the basis for possible further 
investigations at the local registry level.   
In 2015 the Central Registry of EUROCAT was transferred from the University of Ulster to 
the JRC, and became part of the European Platform on Rare Diseases Registration. This is the 
first time the statistical monitoring has been performed by the JRC-EUROCAT Central 
registry.  
We report here the results of the monitoring performed on data for the birth years 2006-2015. 
Cases of congenital anomaly among livebirths, fetal deaths from 20 weeks gestational age 
and terminations of pregnancy for fetal anomaly (TOPFA) at any gestation were included. 
We report both the statistical results and, where available, the outcome of preliminary 
investigations conducted by registries. For each anomaly, the trends in prevalence in each 
registry are shown and in addition the overall pan-European prevalence by single year of 
birth. Some congenital anomalies take a while to be reported; therefore the prevalence in the 
latest data is often underreported. Presenting the overall pan-European prevalence by single 
year allows for the influence of the most recent data (2015) to be evaluated.  
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Key findings 
Trends in Congenital Anomalies excluding genetic conditions  
• Neural tube defects (NTDs) are largely preventable by consuming sufficient folic acid 
immediately before pregnancy and in early pregnancy. Many countries outside Europe have 
introduced the fortification of flour with folic acid and have subsequently observed 
decreases in the prevalence of NTDs. NTDs have not decreased in prevalence over the last 10 
years in Europe. Prevalence rates were 10.10 per 10,000 births in 2006-2007 and 10.27 per 
10,000 births in 2014-2015 indicating the current plan of encouraging women to take folic 
acid supplements before becoming pregnant may not be effective and preventive measures 
should be strengthened in Europe.  
• Severe Microcephaly is monitored closely by EUROCAT due to the recent Zika virus 
outbreaks in South America that started in 2015. The first births in Europe after possible 
exposure to Zika virus occurred in 2016. The reported prevalence of microcephaly across 
Europe is so heterogeneous due to the rarity of the anomaly and discrepant diagnostic 
criteria, that the observed decreasing trend in the 2006-2015 Pan European analysis cannot be 
interpreted to reflect a true decreasing trend. Furthermore, this heterogeneity means that 
analyses performed in future years are unlikely to detect any increase in prevalence of 
microcephaly due to the Zika virus [1]. 
• A decreasing trend in anophthalmos/microphthalmos was detected. Prevalence decreased 
on average by 5.3% per year from 1.14 per 10,000 births in 2006-2007 to 0.82 per 10,000 births 
in 2014-2015. In the Ukraine, which has the highest prevalence of anophthalmos/ 
microphthalmos among all EUROCAT registries, the decrease in prevalence was above 20%, 
which is a good sign given that this anomaly is known to be sensitive to radiation exposure.  
• Increasing trends in both Tricuspid atresia/stenosis and Hypoplastic right heart were 
found. Tricuspid atresia/stenosis increased on average by 5.3% per year from 0.54 per 10,000 
births in 2006-2007 to 0.84 per 10,000 births in 2014-2015, while Hypoplastic right heart 
increased on average by 6.8% per year from 0.44 per 10,000 births in 2006-2007 to 0.63 per 
10,000 births in 2014-2015. These trends will be followed in the next years.  
• A decreasing trend in Hypoplastic left heart was found, with a decline in prevalence by 
2.3% per year, from 2.74 per 10,000 births in 2006-2007 to 2.43 per 10,000 births in 2014-2015. 
This is a very severe anomaly with a high termination rate. It is a new decreasing trend not 
observed in the earlier pan-Europe analyses and will be followed.  
• A decreasing trend in Gastroschisis was found in the pan-Europe analysis. The prevalence 
decreased on average by 2.6% per year from 3.11 per 10,000 births in 2006-2007 to 2.75 per 
10,000 births in 2014-2015. This anomaly is associated with low maternal age [2, 3]. Over the 
past 20 years prevalence has increased mainly in UK and some areas outside Europe [4, 5, 6, 
7].  
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• Increasing trends were found for Congenital hydronephrosis and Multicystic renal 
dysplasia. For Congenital hydronephrosis prevalence increased on average by 2.8% per year 
rising from 9.88 per 10,000 births in 2006-2007 to 12.12 per 10,000 births in 2014-2015. 
Multicystic renal dysplasia increased on average by 1.8% per year rising from 3.85 per 10,000 
births in 2006-2007 to 4.37 per 10,000 births in 2014-2015. For both anomalies, the increase 
might be explained by more frequent use of prenatal ultrasound screening in Europe.  
• An increasing pan-European trend in Club foot (talipes equinovarus) was detected. The 
prevalence of club foot increased on average by 3.4% per year, rising from 8.78 per 10,000 
births in 2006-2007 to 11.44 per 10,000 births in 2014-2015. The increasing trend has already 
been reported in the 2011 and 2012 EUROCAT Statistical Monitoring Reports and will be 
further investigated. 
 • Over the last 10 years, there has been an increase in prevalence of the laterality anomalies 
(on average 2.7% per year), from 1.41 per 10,000 births in 2006-2007 to 1.86 per 10,000 births 
in 2014-2015. This is the first time EUROCAT have presented this data and the increasing 
trend will be followed.   
• There is a continuous decrease in the prevalence of Valproate syndrome in Europe. The 
prevalence of this teratogenic syndrome decreased by 27.5% per year, from 0.13 per 10,000 
births in 2006-2007 to 0.02 per 10,000 births in 2014-2015.  
 
Clusters  
Six clusters in time were detected in individual registry populations which, following 
preliminary investigations, could not be explained by information held within the registries:  
Congenital Cataract in Tuscany (14 cases observed versus six expected); Ventricular Septal 
Defect (VSD) in Tuscany (five cases observed versus one expected); Ebstein’s anomaly in 
Emilia Romagna (five cases observed versus one expected); Hypoplastic right heart in Isle de 
Reunion (five cases observed versus one expected); Hypospadias in Tuscany (six cases 
observed versus one expected); Skeletal dysplasias in Wales (18 cases observed versus seven 
expected).  
The registries involved will continue to monitor these anomalies.  
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1 Introduction 
The EUROCAT network was established in 1979 and from its beginning received European 
Commission’s funding for the central coordinating activities. The EUROCAT Central 
Registry was based in Brussels from 1979 to 1999 and then moved to London, and from 2000 
to 2014 it was hosted by the University of Ulster.  
In 2015 the Central Registry was transferred to the European Commission’s Joint Research 
Centre (JRC) in Ispra, Italy to provide a sustainable solution for the continuation of 
EUROCAT activities, to secure the results of previous work and to keep the network 
functioning [8]. EUROCAT is now an integral part of the European Platform on Rare 
Diseases Registration being developed at the JRC in close collaboration with the EC’s 
Directorate for Health and Food Safety (DG SANTE). 
The transfer of the EUROCAT Central Registry to the JRC was an intensive and complex 
process. During this period it was essential to accomplish numerous legal procedures, 
including the data protection notification, and to create new structures such as secure IT 
systems for data transfer and data management. Hence, the last two years have been devoted 
to the transfer of the Central Registry, and the annual statistical monitoring of trends and 
clusters, which is an important part of EUROCAT’s work, was not performed. The new JRC-
EUROCAT Central Registry is now fully operational and is ready to effectively continue the 
surveillance of congenital anomalies in Europe.  
In the annual statistical monitoring, both trends and clusters in time are analysed in order to 
detect signals of new or increasing teratogenic exposures and monitor progress in the 
prevention of congenital anomalies. Total prevalence rates of 81 subgroups of congenital 
anomalies, including all cases of livebirths, stillbirths/late fetal deaths from 20 weeks 
gestational age, and terminations of pregnancy for fetal anomaly (TOPFA) at any gestation 
are monitored and reported. A full protocol is published online, providing details of the 
rationale and methodology of the statistical monitoring, including changes to methodology 
and software [9].  
A pan-Europe trend analysis enables the monitoring of rare congenital anomalies that have 
too few cases to be monitored at individual registry level, as well as presenting an overview 
of the situation in Europe. Preliminary investigations of trends and clusters have been 
performed at local and central registry level, and summaries of these investigations are 
reported.  The last statistical monitoring report was published on the data from birth years 
2003-2012 [10]. In this report, we have only been able to report limited comparisons with 
trends and clusters identified in previous years.  
The statistical monitoring provides a methodology for the surveillance of congenital 
anomalies as well as a tool for the harmonisation of data collection by the EUROCAT 
registries. The number of variables collected and the way these variables are coded are in 
continuous development in order to adapt to and represent correctly the evolving 
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knowledge on the topic. Identifying trends and clusters can be spurious due to different 
methods of ascertainment, the introduction of new diagnostic methods that increase the 
number of cases detected, and other reasons not related to a real increase/decrease of a given 
pathology. The statistical monitoring that involves all the registries in the investigation at the 
local level of the results found by the Central Registry facilitates this data harmonisation and 
interpretation.  
In 2015, Public Health England’s National Congenital Anomaly and Rare Diseases 
Registration Service (NCARDRS) was established. This new system built on the work of the 
existing regional congenital anomaly registers which only covered 49% of the population. 
NCARDRS’s aim is to provide a comprehensive registration service for all congenital 
anomalies and rare diseases diagnosed and treated in England. In the past two years, much 
has been achieved and national coverage is now in place [11]. However, inevitably during 
such a significant transition period, ascertainment levels have not yet reached the levels 
reported to EUROCAT prior to the transition. This must be kept in mind when reviewing the 
trends and clusters presented in this report from the English registers. 
We report here the results of the statistical monitoring performed on births over the ten year 
period 2006-2015 on data from 22 EUROCAT registries to describe trends, and from 16 
EUROCAT registries to detect recent clusters in time. The number of registries included in 
the analysis is slightly less than in previous years. Two full registries have not signed the 
JRC-EUROCAT collaboration agreement, which is the legal basis that allows the JRC-
EUROCAT Central Registry to collect, manage and analyse the data from each registry 
member, whilst seven registries are more than one year behind in data transmission and are 
therefore not eligible to be included in the analysis. This also explains the population 
coverage decrease from the previous monitoring report, from about 6 million to 4.7 million 
in the present report.   
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2 Population and Monitoring Process 
2.1 Registries included in the 2006-2015 trend analysis   
At the time of statistical monitoring in spring 2017, there were 33 full member registries in 
EUROCAT (see Appendix A). Twenty-two full member registries met the inclusion criteria 
for the individual 10-year trend analysis, and 16 met the inclusion criteria for the cluster 
analysis (see Box 1). 
 
Box 1.  Registry inclusion/exclusion criteria for trend analysis  
— Registries >1 year late with data transmission excluded from analysis 
— Pan-Europe: Registries with 9 or 10 years of continuous data starting from 2006 included (i.e. 2006-
2014 or 2006-2015) 
— Individual registry analysis: Registries with 8 or 10 years of continuous data included (i.e. 2007-
2014 or 2008-2015 or 2006-2015) 
 
Denmark and Hungary did not sign the JRC-EUROCAT collaboration agreement and 
therefore did not send data to the Central Registry for the years 2013 - 2015.  Styria, 
Auvergne, Paris, Dublin, Norway, Wielkopolska, and East Midlands & South Yorkshire were 
more than one year behind in data transmission. French West Indies and Brittany were 
excluded from the trend analysis having less than eight years of data in the monitoring time 
period.  
All the other registries were included in the Pan-European trends analysis (see Appendix A). 
Considering that the last statistical monitoring report was published three years ago on the 
data from birth years 2003-2012, and that the number of registries included in the current 
analysis is slightly less than in previous years, a deviation from the protocol was done for 
Valencia Region, that had only eight years of continuous data.   
 
2.2  Registries included in the 2015 cluster analysis  
EUROCAT defines clusters as: 'An aggregation of cases of congenital anomaly in time 
and/or space which appears to be unusual'. Registries classified as “early response” i.e. 
registries that meet the EUROCAT data transmission deadline of the 15th February, with data 
for the most recent five years (2011-2015) were included in cluster monitoring (see Box 2). 
Five years is considered an optimal period for cluster monitoring as the inclusion of more 
than five years data may detect trends rather than clusters, while less than five years may fail 
to detect clusters if the most recent years are unusual compared to preceding years [9].  
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Box 2. Registry inclusion criteria for cluster analysis 
— Registries must have transmitted data for all years 2011-2015 
— Registries must have transmitted full date of birth information  
— Registries must have individual case data (i.e. full member registries only)   
— Registries must have a stable birth population (annual birth population changes must be less than 
+/- 10%) 
 
A total of 16 full member registries transmitted year 2015 data to the EUROCAT Central 
Registry in February 2017 (see Appendix A).  All these registries were included in the cluster 
analysis.  
Where registries do not meet the data transmission deadline, monitoring can be run locally 
to detect clusters and trends using software available in the EDMP. Pan-Europe monitoring 
can only be conducted centrally as it uses data from all the registries combined.  
Registries are encouraged to use the EDMP statistical monitoring function in the periods 
between annual Statistical Monitoring to look for clusters or trends in more recent data. 
 
2.3 What was monitored?  
Cases included livebirths, stillbirths from 20 weeks gestational age and TOPFA at any 
gestation.  
For the 23 registries included in the trend and/or cluster analysis in the period 2006-2015, 
79.0% of cases were liveborn, 1.9% were stillborn and 19.1% were TOPFA. Type of birth was 
unrecorded for a small proportion of cases (0.04%) which are included in the monitoring to 
avoid missing a potential cluster or trend.    
Statistical monitoring is conducted to detect changes in time within individual registries, and 
also to detect trends across all registries (pan-Europe trends). Seventy-nine EUROCAT 
congenital anomaly subgroups (non-genetic cases only) plus the three trisomy subgroups 
adjusted for maternal age and fetal survival to 20 weeks were included in both the pan-
Europe and individual registry trend analyses (see Appendix B for the list of anomaly 
subgroups included). Trend tests were performed for the most recent ten years of data (or 
eight years if 10 years were unavailable) for every registry and for ten years of data at pan-
European level.   
Cluster analysis, which detects clusters or deficits occurring in the last two years (2014-2015) 
that are less than 18 months in length, was run on 75 EUROCAT subgroups of congenital 
anomalies (see Appendix B for the for the list of anomaly subgroups included and Appendix 
C for summary of statistical methods). 
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The following analyses were carried out:  
 Analysis of individual registry trends and pan-Europe trends for 22 registries 
covering 4.71 million births (2006-2015) 
 Cluster analysis to detect unusual aggregations of cases in 16 registries covering 0.69 
million births (2014-2015) 
 
2.4 Investigation process 
The results of the statistical monitoring were reviewed by the JRC-EUROCAT Management 
Committee (MC) in May 2017. Registries were asked to investigate clusters and 10-year 
trends detected in the monitoring. The MC selected congenital anomalies with significant 
increasing or decreasing trends for preliminary investigation using a predefined 
prioritisation protocol (see Figure 1). The anomalies were selected based on the pattern of the 
trend identified in the pan-Europe analysis. 
 
Fig. 1:  Prioritisation criteria for the investigation of ten year trends [4] 
 
Each registry was sent the results of the trends and cluster analysis for their data. Each 
registry was asked to conduct preliminary investigations using standardised guidelines (see 
Appendix D). The significant increasing and decreasing trends selected for registry 
investigation are listed in Appendix E. Registries were also given the option to investigate 
and report on increasing and decreasing trends detected at local registry level only.  
Registries reported their findings to the JRC-EUROCAT Central Registry using standard 
reporting templates [9]. They were asked to provide specific details including the 
investigation methods, the results of the preliminary investigation and the public health 
authorities that were notified.   
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Trends not prioritised for investigation are not discussed in this report but will be subject to 
further monitoring. 
The preliminary reports of the trend and cluster investigations were reviewed by the JRC-
EUROCAT MC. The individual registry preliminary investigation reports into identified 
trends and clusters are available on the membership-only section of the EUROCAT website.  
 
2.5 Statistical software updates from the previous report  
No changes were made to the software for this year’s statistical monitoring. For a full 
description of statistical software updates in previous years, please see the EUROCAT 
Statistical Monitoring Protocol 2012 at the EUROCAT website [9].  
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3 Pan-European Trends  
3.1 Overview  
The pan-Europe trend analysis was carried out for the time period 2006-2015. The analysis 
included data from 22 full member registries. Registries that were more than one year late 
with data transmission were excluded from analysis. Some of the larger registries (e.g. 
Hungary, East Midlands & South Yorkshire, Paris) were not included this year for various 
reasons which are outlined in Appendix A.  
The trend analysis included 79 subgroups, plus the three trisomy subgroups adjusted for 
maternal age and fetal survival to 20 weeks. The analysis identified increasing trends for 
eight congenital anomaly subgroups and decreasing trends for 18 subgroups (Figure 2 and 
Appendix E).   
The increasing trends in the pan-Europe analysis were identified for the following 
subgroups: Ventricular Septal Defect (VSD); Atrial Septal Defect (ASD); Tricuspid atresia 
and stenosis; Hypoplastic right heart; Multicystic renal dysplasia; Congenital 
hydronephrosis; Club foot – talipes equinovarus; Laterality Anomalies.   
The decreasing trends in the pan-Europe analysis were identified for the following anomaly 
subgroups: Hydrocephaly; Severe microcephaly; Anophthalmos/microphthalmos; 
Pulmonary valve stenosis; Hypoplastic left heart; Patent ductus arteriosus (PDA); Cleft lip 
with or without palate; Cleft palate; Gastroschisis; Hypospadias; Syndactyly; Vascular 
disruption anomalies; Congenital constriction bands; Conjoined twins; Valproate syndrome; 
Genetic syndromes + microdeletions; Klinefelter syndrome; Down syndrome age adjusted.  
This section provides details of the result, and the investigations and the interpretation of 
pan-Europe trends for specific anomaly subgroups (for the summary of significant 10-year 
increasing and decreasing trends detected in the pan-Europe analysis 2015 see also 
Appendix E).  
For each congenital anomaly subgroup, the trends in prevalence in each registry are shown 
and the overall pan-European prevalence by single year of birth. This enables the influence 
of the most recent data (2015) to be evaluated as some anomalies are reported late, which can 
result in the prevalence in the latest data being underreported. 
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Fig. 2: Estimated average percentage change in the prevalence and 95% confidence intervals (pan-
Europe analysis 2006-2015)  
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3.2 Increasing trends identified at the pan-Europe level 
 
Ventricular septal defect (VSD)  
VSD is a defect in the ventricular septum of the heart. The size of the opening can vary from 
a few millimetres to large holes leaving most of the ventricular septum absent, creating one 
common ventricle. VSD usually does not cause symptoms at birth and often manifests a 
couple of weeks after birth. The defect may be associated with Down syndrome and other 
genetic syndromes, but most infants with VSD have no associated anomalies. 
The pan-Europe analysis showed that the prevalence of VSD is increasing on average 0.7% 
per year (Fig. 3a). Six registries (Basque Country, Zagreb, Antwerp, Isle de Reunion, Ukraine 
and Tuscany) had statistically significant increasing trends and five registries had 
significantly decreasing trends (South Portugal, Northern England, Wales, Vaud and Cork 
and Kerry). Figure 3b shows the annual prevalence and indicates that the increase in 
prevalence may be an underestimate, because the prevalence in 2015 is likely to be 
underreported.  
VSD is diagnosed by a murmur and confirmed on an echocardiography. In regions with 
routine paediatric examinations of all newborns and with easy access to echocardiography, 
the number of infants diagnosed with small defects will be high. It is expected that all VSDs 
requiring surgery will be diagnosed in all areas. Therefore, the observed increasing trend 
may not be a true increase but due to the heterogeneity of the diagnosis.   
 
Fig. 3a: Ventricular Septal Defect (VSD) - Estimated average percentage change in the prevalence and 95% 
confidence intervals for the registries included in the pan-Europe trend analysis.   
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Fig. 3b: Ventricular Septal Defect (VSD) - Prevalence and 95% confidence intervals for the registries included in 
the pan-Europe trend analysis. 
 
 
Atrial septal defect (ASD)  
ASD is a defect in the atrial septum, causing a flow of blood between the left and right 
atrium. ASD may not produce noticeable signs or symptoms in infancy or childhood and 
may therefore be diagnosed late, especially if the defect is small. In fetal life there is a natural 
flow of blood from the right to the left atrium. After birth this defect will close, but 
sometimes remain open for weeks or months as a persistent foramen ovale. EUROCAT 
recommends reporting only defects in the atrial septum where six months after birth there is 
flow across the defect. 
The pan-Europe analysis showed that the prevalence of ASD is increasing on average 1.0% 
per year (Fig. 4a). Three registries had statistically significant increasing trends (South 
Portugal, Saxony-Anhalt and Tuscany), and three registries had significantly decreasing 
trends (Valencia Region, Northern England and Wales). The overall increasing trend appears 
to be influenced by the increases up until 2011 (Fig. 4b). 
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Fig. 4a: Atrial septal defect (ASD) - Estimated average percentage change in the prevalence and 95% confidence 
intervals for the registries included in the pan-Europe trend analysis.  
 
Fig. 4b: Atrial septal defect (ASD) - Prevalence and 95% confidence intervals for the registries included in the 
pan-Europe trend analysis. 
It is difficult, even using echocardiography, to discriminate between persistent foramen 
ovale and ASD. The growing use of echocardiography in neonatal intensive care may explain 
the rise in number of ASDs reported to EUROCAT. Due to the extreme heterogeneity in 
ascertainment of ASD between the registries, the changes in prevalence over the years 
should not be interpreted as a true trend. In the future, an additional analysis of the pan-
European trend on cases with ASD that require surgery could be performed in order to be 
more consistent in the identification of a true trend.  However, this will reduce the sample 
size as some registries do not report the surgery variable and some children may have 
surgery very late. Most surgeries are performed before the age of five years, but may also be 
performed later.  
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Tricuspid atresia and stenosis  
Tricuspid atresia and stenosis is a severe congenital heart defect. It is usually associated with 
the underdevelopment of the right ventricle. The anomaly is so rare that only the pan-
Europe trend can provide any information.  
The pan-Europe analysis showed that the prevalence of Tricuspid atresia and stenosis is 
increasing on average 5.3% per year (Fig. 5). However, no significantly increasing trends 
were identified for any of the registries included in the pan-European trend analysis.  Figure 
5b indicates that the true increase in prevalence may be greater as the prevalence in 2015 is 
likely to be underreported. We do not know at present if the observed increase is due to a 
real increase in prevalence or because the reporting of this anomaly has increased due to the 
coding tips written by the Coding Committee in 2013 focusing on this anomaly. The trend 
will be followed and investigated in more detail.  
 
Fig. 5a: Tricuspid atresia and stenosis - Estimated average percentage change in the prevalence and 95% 
confidence intervals for the registries included in the pan-Europe trend analysis.   
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Fig. 5b: Tricuspid atresia and stenosis - Prevalence and 95% confidence intervals for the registries included in the 
pan-Europe trend analysis. 
Hypoplastic right heart 
Hypoplastic right heart is one of the univentricular cardiac anomalies with 
underdevelopment of the right ventricle. Most cases also have tricuspid atresia or pulmonary 
atresia with intact ventricular septum. The anomaly is so rare that only the pan-Europe trend 
can provide any information. The overall pan-European trend is increasing (on average 6.8% 
per year) and is significant (Fig. 6a and 6b), whilst no significantly increasing trends were 
identified for any of the registries. We do not know at present if the observed increase is due 
a real increase in prevalence or because the reporting of this anomaly has increased due to 
the coding tips written by the Coding Committee in 2013 focusing on this anomaly. The 
trend will be followed and investigated in more detail.  
 
Fig. 6a:  Hypoplastic right heart - Estimated average percentage change in the prevalence and 95% confidence 
intervals for the registries included in the pan-Europe trend analysis. 
0
.5
1
1
.5
P
re
v
a
le
n
c
e
  
(p
e
r 
1
0
,0
0
0
 b
ir
th
s
)
2005 2007 2009 2011 2013 2015
Year
Antwerp [0.5]
Summary estimate [0.4]
South West England [0.4]
Ukraine [1.0]
Vaud [1.3]
Hainaut [0.1]
Tuscany [0.1]
N Netherlands [0.3]
Emilia Romagna [0.1]
Zagreb [0.1]
Malta [0.2]
S Portugal [0.2]
Basque Country [0.6]
Saxony Anhalt [0.4]
Mainz [0.3]
Cork and Kerry [0.4]
Wales [0.6]
Isle de Reunion [0.8]
Thames Valley [0.1]
Northern England [0.3]
SE Ireland [1.1]
Valencia Region [0.1]
Wessex [0.9]
Hypoplastic right heart [prevalence per 10,000]
30% 20% 10%  10% 20% 30%No
change
<-- Decrease        Increase -->
Average annual change in prevalence
Non-linear change
Rate of change
Too few cases
 21 
 
Fig. 6b:  Hypoplastic right heart - Prevalence and 95% confidence intervals for the registries included in the pan-
Europe trend analysis. 
 
Congenital hydronephrosis  
Congenital hydronephrosis is mainly diagnosed prenatally. Cases have to be followed up as 
some intrauterine diagnoses are not confirmed after birth. Only cases where renal pelvis is ≥ 
10 mm after birth should be reported to EUROCAT. Hydronephrosis caused by vesico-
ureteral reflux should not be reported to EUROCAT.  
The pan-Europe analysis showed that the prevalence of congenital hydronephrosis is 
increasing on average by 2.8% per year (Fig. 7a). Twelve registries had increasing trends, six 
of them were significantly increasing: Antwerp, Basque Country, Emilia Romagna, Mainz, 
Thames Valley and Valencia Region, and Wales was significantly decreasing. Figure 7b 
indicates that the true increase in prevalence may be greater as the prevalence in 2015 is 
likely to be underreported. The increase might be explained by more frequent use of prenatal 
ultrasound screening in Europe. 
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Fig. 7a:  Congenital hydronephrosis - Estimated average percentage change in the prevalence ad 95% confidence 
intervals for the registries included in the pan-Europe trend analysis.   
 
 
Fig. 7b:  Congenital hydronephrosis - Prevalence and 95% confidence intervals for the registries included in the 
pan-Europe trend analysis. 
 
Multicystic renal dysplasia  
Bilateral multicystic renal dysplasia is usually lethal shortly after birth. Unilateral multicystic 
renal dysplasia is much more common, is asymptomatic and usually diagnosed prenatally. 
Kidneys with multicystic renal dysplasia usually undergo atrophy within the first year after 
birth. If diagnosed later in life, the diagnosis will be renal agenesis. The pan-Europe analysis 
showed that the prevalence of multicystic renal dysplasia is increasing on average by 1.8% 
per year (Fig. 8a and 8b). Seven registries had increasing trends of which only two (North 
Netherlands and Thames Valley) were significantly increasing, and three were significantly 
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decreasing (Wessex, Saxony Anhalt, Hainaut). The increased pan-Europe trend might be 
explained by more frequent use of prenatal ultrasound screening in Europe. 
 
Fig. 8a:  Multicystic renal dysplasia - Estimated average percentage change in the prevalence and 95% confidence 
intervals for the registries included in the pan-Europe trend analysis. 
 
 
Fig. 8b:  Multicystic renal dysplasia - Prevalence and 95% confidence intervals for the registries included in the 
pan-Europe trend analysis. 
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Club foot – talipes equinovarus  
Club foot can be unilateral or bilateral and has a familial pattern of inheritance. Club foot 
cases requiring surgery or Ponseti treatment [12] should be reported to EUROCAT as a major 
congenital anomaly. If the club foot is of postural origin and not receiving treatment as 
mentioned, the anomaly should be classified as a minor anomaly.  
The pan-Europe analysis showed that the prevalence of club foot is increasing on average by 
3.4% per year. Six registries (Antwerp, Northern England, North Netherlands, Ukraine, 
Valencia Region, Vaud) had significantly increasing and three registries had significantly 
decreasing trends (South Portugal, Tuscany, Wales). (Fig. 9a) The significant increasing trend 
remains after the data from Northern England is removed. The increase in Northern England 
was due to a change in coding practice, however, there is no explanation of the increased 
trend in other registries for this anomaly. This increasing trend (Fig. 9b) has already been 
reported in the 2012 EUROCAT Statistical Monitoring Reports [10] and is being investigated. 
 
 
 
 
Fig. 9a:  Club foot – talipes equinovarus - Estimated average percentage change in the prevalence and 95% 
confidence intervals for the registries included in the pan-Europe trend analysis. 
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Fig. 9b:  Club foot – talipes equinovarus - Prevalence and 95% confidence intervals for the registries included in 
the pan-Europe trend analysis. 
 
Laterality Anomalies 
This is a new subgroup of anomalies which includes atrial isomerisms, dextrocardia, 
bronchopulmonary isomerism, situs inversus and anomalies of spleen. The pan-Europe 
analysis showed that the prevalence of laterality anomalies is increasing on average by 2.7% 
per year. The increasing trend is significant only at the pan-Europe level, but 13 registries 
show not significant increasing trends (Fig. 10a).  Figure 10b indicates that the true increase 
in prevalence may be greater as the prevalence in 2015 is likely to be underreported.  The 
increasing trend will be followed as it is of interest because a potential association with 
maternal diabetes [13].  
 
 
Fig. 10a:  Laterality Anomalies – Estimated average percentage change in the prevalence and 95% confidence 
intervals for the registries included in the pan-Europe trend analysis. 
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Fig. 10b:  Laterality Anomalies – Prevalence and 95% confidence intervals for the registries included in the pan-
Europe trend analysis. 
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3.3 Decreasing trends identified at the pan-Europe level 
Hydrocephaly 
The definition of hydrocephaly is dilatation of the ventricular system with impaired 
circulation and absorption of the cerebrospinal fluid. The dilatation should not be due to 
primary atrophy of the brain, with or without enlargement of the skull.  
The pan-Europe analysis showed that the prevalence of hydrocephaly is decreasing on 
average by 1.6% per year. A decreasing trend is reported in 13 registries (Basque Country, 
Wessex, Emilia-Romagna, Valencia Region, South West England, Tuscany, North 
Netherlands, Northern England, Ukraine, Wales, Hainaut, Cork & Kerry) but only at the 
pan-Europe level and in Wales it is statistically significant (Fig. 11a). The decreasing trend in 
this anomaly was not observed earlier and not reported in the 2012 Statistical Monitoring 
Report [10]. 
 
 
Fig. 11a:  Hydrocephaly – Estimated average percentage change in the prevalence and 95% confidence intervals 
for the registries included in the pan-Europe trend analysis. 
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Fig. 11b:  Hydrocephaly – Prevalence and 95% confidence intervals for the registries included in the pan-Europe 
trend analysis. 
 
 
Severe microcephaly 
Severe microcephaly should be reported if head circumference (occipito-frontal) is less than  
-3 SD for sex and GA. This anomaly will be followed closely due to the recent Zika virus 
outbreaks that started in 2015 in South America. The first births in Europe after possible 
exposure to Zika virus occurred in 2016.  
A decreasing trend is reported in nine registries but only at the pan-Europe level (-4.2% per 
year), South West England and in Wales it is statistically significant (Fig. 12a). The reported 
prevalence of microcephaly across Europe (Fig. 12a) is so heterogeneous due to the rarity of 
the anomaly and discrepant diagnostic criteria that the decreasing trend observed in the 
2006-2015 Pan European analysis (Fig. 12b) cannot be interpreted to reflect a true decrease in 
prevalence. Furthermore, this heterogeneity means that analyses performed in future years 
are unlikely to detect any increase in prevalence of microcephaly due to the Zika virus [1]. 
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Fig. 12a: Severe microcephaly – Estimated average percentage change in the prevalence ad 95% confidence 
intervals for the registries Included in the pan-Europe trend analysis. 
 
 
 
Fig. 12b: Severe microcephaly - Prevalence and 95% confidence intervals for the registries included in the pan-
Europe trend analysis. 
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Anophthalmos/microphthalmos 
Anophthalmos is a unilateral or bilateral absence of the eye tissue. Microphthalmos is 
defined as small eye/eyes with smaller than normal axial length.   
The pan-Europe analysis showed that the prevalence of anophthalmos/microphthalmus is 
decreasing on average by 5.3% per year. Only the large decrease in Ukraine (-20% per year) 
is statistically significant. This decrease will continue to be monitored. 
 
 
Fig. 13a: Anophthalmos/microphthalmos - Estimated average percentage change in the prevalence and 95% 
confidence intervals for the registries included in the pan-Europe trend analysis. 
 
 
Fig. 13b: Anophthalmus/microphthalmus - Prevalence and 95% confidence intervals for the registries included in 
the pan-Europe trend analysis. 
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Pulmonary valve stenosis 
Pulmonary valve stenosis is defined as obstruction or narrowing of the pulmonary valves 
which may impair blood flow through the valves. The anomaly covers all spectra of severity 
- from small stenosis to critical pulmonary valve stenosis in severely ill neonates. There is a 
significant decreasing pan-Europe trend (-3.5%) for this anomaly, maybe due to less 
reporting of small gradients (less severe cases). Due to the heterogeneity of the prevalence 
between the registries, this decreasing pan-Europe trend has to be interpreted with caution. 
 
Fig. 14a: Pulmonary valve stenosis – Estimated average percentage change in the prevalence and 95% confidence 
intervals for the registries included in the pan-Europe trend analysis. 
 
Fig. 14b: Pulmonary valve stenosis – Prevalence and 95% confidence intervals for the registries included in the 
pan-Europe trend analysis. 
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Hypoplastic left heart 
Hypoplastic left heart is a spectrum of cardiac defects characterized by severe 
underdevelopment of the left side of the heart. The definition includes atresia or marked 
hypoplasia of aortic orifice or valve with hypoplasia of ascending aorta and defective 
development of left ventricle (with or without mitral valve stenosis/atresia). This is a very 
severe anomaly with a high termination rate.  
A decreasing trend is reported in 12 registries but only at the pan-Europe level (-2.3% per 
year) and in Wessex it is statistically significant (Fig. 15a). It is a new decreasing trend that 
will be followed.  
 
Fig. 15a: Hypoplastic left heart - Estimated average percentage change in the prevalence and 95% confidence 
intervals for the registries included in the pan-Europe trend analysis.  
 
 
Fig. 15b: Hypoplastic left heart - Prevalence and 95% confidence intervals for the registries included in the pan-
Europe trend analysis. 
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Patent ductus arteriosus (PDA) 
Patent ductus arteriosus is considered a major anomaly only if it occurs in term born babies 
(GA ≥ 37 weeks). Cases should be reported only if the PDA is still present six months after 
birth or if surgery/catheter closure is required. Many critically ill neonates have an open 
PDA for days or weeks with spontaneous closure. These babies should not be reported to 
EUROCAT. The pan-Europe analysis showed that the prevalence of PDA is decreasing on 
average by 5.3% per year (Fig. 16a). The decreasing trend in prevalence may be less as the 
prevalence in 2015 is likely to be underreported and has inflated the estimated decrease (Fig. 
16b). The pan-Europe trend is decreasing most probably due to more restrictive reporting. 
 
Fig. 16a: Patent ductus arteriosus (PDA) - Estimated average percentage change in the prevalence and 95% 
confidence intervals for the registries included in the pan-Europe trend analysis. 
 
Fig. 16b: Patent ductus arteriosus (PDA) – Prevalence and 95% confidence intervals for the registries included in 
the pan-Europe trend analysis. 
Tuscany [1.3]
Valencia Region [6.7]
Antwerp [2.0]
Emilia Romagna [1.5]
Isle de Reunion [1.7]
Wessex [0.9]
Hainaut [0.1]
Malta [2.0]
Mainz [0.0]
Thames Valley [0.6]
SE Ireland [1.3]
Zagreb [2.8]
Vaud [2.8]
Ukraine [3.1]
S Portugal [0.8]
N Netherlands [1.5]
Summary estimate [2.4]
Basque Country [3.0]
South West England [0.5]
Wales [4.6]
Northern England [1.9]
Cork and Kerry [3.4]
Saxony Anhalt [8.6]
Patent ductus arteriosus [prevalence per 10,000]
30% 20% 10%  10% 20% 30%No
change
<-- Decrease        Increase -->
Average annual change in prevalence
Non-linear change
Rate of change
Too few cases
0
1
2
3
4
P
re
v
a
le
n
c
e
  
(p
e
r 
1
0
,0
0
0
 b
ir
th
s
)
2005 2007 2009 2011 2013 2015
Year
 34 
Cleft lip with or without palate 
This is an anomaly where clefting of the upper lip occurs with or without clefting of the 
maxillary alveolar process and hard and soft palate. This anomaly is visible at birth and 
should have a high ascertainment rate. There is a known geographical difference in 
prevalence throughout Europe. The pan-Europe analysis showed that the prevalence of cleft 
lip is decreasing on average by 1.2% per year. This decrease is likely to be a chance finding, 
because the statistical significance is borderline. No single registry shows a significant rate of 
change despite the high number of cases (Fig. 17a) and the pan-European prevalence has 
fluctuated greatly over the past 10 years (Fig. 17b).  
 
Fig. 17a: Cleft lip with or without palate - Estimated average percentage change in the prevalence ad 95% 
confidence intervals for the registries Included in the pan-Europe trend analysis. 
 
Fig. 17b: Cleft lip with or without palate - Prevalence and 95% confidence intervals for the registries included in 
the pan-Europe trend analysis. 
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Cleft palate 
Cleft palate is defined as fissure defect of the soft and/or hard palate(s) or submucous cleft 
without cleft lip. The anomaly may be diagnosed days or weeks after birth. It is often 
associated with other severe anomalies that may have a high termination rate, in which case 
this specific anomaly might not be reported.   
The pan-Europe analysis showed that the prevalence of cleft palate is decreasing on average 
by 1.6% per year. The significant overall decreasing trend (-1.6% per year) also occurred in 
Wessex, north Netherlands, Zagreb and Malta. Northern England was the only registry with 
a significantly increasing trend (Fig. 18a). The decreasing trend in prevalence may not be 
`true’ as the prevalence in 2015 is likely to be underreported (Fig. 18b) which will inflate the 
estimated decrease and the pan-European prevalence has fluctuated greatly over the past 10 
years. 
 
Fig. 18a: Cleft palate – Estimated average percentage change in the prevalence and 95% confidence intervals for 
the registries included in the pan-Europe trend analysis. 
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Fig. 18b: Cleft palate – Prevalence and 95% confidence intervals for the registries included in the pan-Europe 
trend analysis. 
 
 
Gastroschisis 
Gastroschisis is defined as protrusion of abdominal contents through an abdominal wall 
defect lateral to an intact umbilical cord and not covered by a membrane. It is associated 
with low maternal age. Over the past 20 years prevalence has increased mainly in UK and 
also described in other areas outside Europe [4, 5, 6, 7]. The pan-Europe decrease (-2.6% per 
year) involves many UK registries (South West England, Wessex, Thames Valley, Northern 
England, Wales) as well as Isle de Reunion, Hainaut and Ukraine (Fig. 19). The decreasing 
trend appears to be mainly due to a step change in prevalence from 2010 to 2011 (Fig. 19b). 
Since this anomaly is associated with low maternal age [2, 3], the decreasing trend will be 
investigated in more detail to investigate whether the decrease can be explained by a 
decrease in the number of teenage pregnancies.  
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Fig. 19a: Gastroschisis – Estimated average percentage change in the prevalence and 95% confidence intervals for 
the registries included in the pan-Europe trend analysis. 
 
Fig. 19b: Gastroschisis – Prevalence and 95% confidence intervals for the registries included in the pan-Europe 
trend analysis. 
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Hypospadias 
In hypospadias the urethral meatus is abnormally located and is displaced proximally on the 
ventral surface of the penis. There are many reports of increasing trends over the last 20 
years and an association to endocrine disrupters has been proposed. This is the first time a 
pan-Europe decrease is observed (-1.9% per year, Fig. 20a). Figure 20b indicates that the 
decreasing trend is likely to be highly influenced by the low prevalence in 2015.  Follow up 
of this trend is not needed but this anomaly will continue to be monitored.  
 
 
Fig. 20a: Hypospadias - Estimated average percentage change in the prevalence and 95% confidence intervals for 
the registries included in the pan-Europe trend analysis. 
 
 
Fig. 20b: Hypospadias - Prevalence and 95% confidence intervals for the registries included in the pan-Europe 
trend analysis. 
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Syndactyly 
Syndactyly is defined as partial or total webbing between 2 or more digits, with the exclusion 
of syndactyly between 2nd and 3rd toes.  
The overall pan-Europe decrease in prevalence of syndactyly is of -3.1% per year (Fig. 21a). 
Fig 21b indicates that the decreasing trend is likely to be due to the low prevalence in 2015. 
 
Fig. 21: Syndactyly – Estimated average percentage change in the prevalence and 95% confidence intervals for the 
registries included in the pan-Europe trend analysis. 
 
 
Fig. 21b: Syndactyly – Prevalence and 95% confidence intervals for the registries included in the pan-Europe 
trend analysis. 
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Congenital constriction bands 
This rare anomaly is part of the vascular disruption subgroup. There is an overall decrease in 
prevalence of -4.1% per year with borderline significance (Fig. 22). The decrease is likely to 
be highly influenced by the high prevalence in 2006 (Fig. 22b).   
 
 
Fig. 22a: Congenital constriction bands – Estimated average percentage change in the prevalence and 95% 
confidence intervals for the registries included in the pan-Europe trend analysis 
 
Fig. 22b: Congenital constriction bands – Prevalence and 95% confidence intervals for the registries included in 
the pan-Europe trend analysis. 
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Conjoined twins 
The occurrence of conjoined twins is very rare, with a pan-Europe prevalence of 0.1 per 
10,000 births. No significant trends were reported previously for this anomaly, while there 
was a significant decrease of -9.4% per year in this year’s investigation (Fig. 23a). The 
condition is so rare that only biennial pan-European prevalence estimates can be reliably 
estimated and no individual registry has enough cases to investigate trends (Fig. 23b).  
 
Fig. 23a: Conjoined twins – Estimated average percentage change in the prevalence and 95% confidence intervals 
for the registries included in the pan-Europe trend analysis. 
 
Fig. 23b: Conjoined twins – Prevalence and 95% confidence intervals for the registries included in the pan-Europe 
trend analysis. 
 
 
Hainaut [0.2]
Tuscany [0.1]
N Netherlands [0.0]
Emilia Romagna [0.0]
Vaud [0.2]
Zagreb [0.2]
Malta [0.2]
S Portugal [0.0]
Antwerp [0.0]
Basque Country [0.1]
Saxony Anhalt [0.0]
Mainz [0.7]
Cork and Kerry [0.4]
Wales [0.2]
Ukraine [0.3]
Isle de Reunion [0.1]
Thames Valley [0.1]
Wessex [0.3]
Northern England [0.4]
SE Ireland [0.1]
South West England [0.1]
Valencia Region [0.1]
Summary estimate [0.1]
Conjoined twins [prevalence per 10,000]
20% 10%  10% 20%No
change
<-- Decrease        Increase -->
Average annual change in prevalence
Non-linear change
Rate of change
Too few cases
0
.1
.2
.3
.4
P
re
v
a
le
n
c
e
  
(p
e
r 
1
0
,0
0
0
 b
ir
th
s
)
2005 2007 2009 2011 2013 2015
Year
 42 
Valproate syndrome 
Valproate syndrome is a teratogenic syndrome. There is a significant annual decrease (-
27.5%, Fig. 24) in this syndrome. The numbers of cases are extremely small; 12 in 2006-7; 
seven in 2008-9; four in 2010-11; one in 2012-13 and two in 2014-15. No yearly prevalence is 
presented. 
In Europe, the therapy prescribed to pregnant women with epilepsy or bipolar disorder has 
changed as recommended by the European Medicines Agency (EMA) [14].  
 
 
 
Fig. 24: Valproate syndrome – Estimated average percentage change in the prevalence and 95% confidence 
intervals for the registries included in the pan-Europe trend analysis. 
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Genetic syndromes and microdeletions 
With the increasing number of genetic tests an increase in the reporting of genetic syndromes 
is to be expected. Conversely, clinical diagnosis might have overestimated the real number of 
cases in previous years. The decreasing trend (-1.8% per year, Fig. 25) is probably due to a 
high prevalence in 2005 and a low prevalence in 2015 possibly due to late confirmations of 
diagnosis based on genetic testing.  
 
 
 
Fig. 25a: Genetic syndromes and microdeletions – Estimated average percentage change in the prevalence and 
95% confidence intervals for the registries included in the pan-Europe trend analysis. 
 
 
Fig. 25b: Genetic syndromes and microdeletions – Prevalence and 95% confidence intervals for the registries 
included in the pan-Europe trend analysis. 
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Klinefelter syndrome 
Klinefelter syndrome (XXY karyotype) is frequently detected due to the prenatal diagnostics 
used to diagnose Down syndrome. The decreasing trend (-7.6% per year, Fig. 26) in 
Klinefelter syndrome observed prior to 2012 reflects the change in clinical practice in the UK 
of not performing full prenatal karyotyping. Four of the registries with decreasing trends are 
in the UK. 
 
Fig.26a: Klinefelter syndrome - Estimated average percentage change in the prevalence and 95% confidence 
intervals for the registries included in the pan-Europe trend analysis. 
 
Fig.26b: Klinefelter syndrome - Prevalence and 95% confidence intervals for the registries included in the pan-
Europe trend analysis. 
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Down syndrome age adjusted 
Down syndrome is due to an additional chromosome 21. The risk of a Down syndrome 
pregnancy is highly associated with increasing maternal age. Therefore, any increasing or 
decreasing trends should be investigated only once maternal age is adjusted for.  This is only 
possible for the 11 registries that report the number of unaffected pregnancies in their 
population by five year maternal age groups (Fig 27a). Any observed trends are unlikely to 
be true changes in prevalence, but are likely to be due to changes in reporting. The 
decreasing trend for age adjusted Down syndrome appears to be highly influenced by the 
low prevalence in 2015. Only one registry had a significantly decreasing trend (Vaud) and 
one a significantly increasing trend (S. Portugal). It is the first time the trend for the age 
adjusted Down syndrome has decreased. The decreasing trend in prevalence may be 
negligible as the prevalence in 2015 is likely to be underreported and this has inflated the 
estimated decrease.  
 
Fig. 27a: Down syndrome age adjusted - Estimated average percentage change in the prevalence and 95% 
confidence intervals for the registries included in the pan-Europe trend analysis. 
 
Fig. 27b: Down syndrome age adjusted - Prevalence and 95% confidence intervals for the registries included in 
the pan-Europe trend analysis. 
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Vascular disruption anomalies 
It’s a new subgroup including all anomalies where the aetiology is thought to be vascular 
disruption. Anomalies included are small intestinal atresia, gastroschisis, limb reduction 
defects, amniotic bands, hydranencephaly, Moebius syndrome. The pan-Europe trend is 
decreasing (-7.5% per year; Fig. 28a) and will be followed. The individual subgroups are also 
decreasing, although only gastroschisis was statistically significant. The decreasing trend in 
prevalence may be less as the prevalence in 2015 is likely to be underreported and has 
inflated the estimated decrease (Fig. 28b). 
 
Fig. 28a: Vascular disruption anomalies - Estimated average percentage change in the prevalence and 95% 
confidence intervals for the registries included in the pan-Europe trend analysis. 
 
 
Fig. 28b: Vascular disruption anomalies - Prevalence and 95% confidence intervals for the registries included in 
the pan-Europe trend analysis. 
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4 Clusters 
4.1 Overview 
EUROCAT defines a cluster as: “An aggregation of cases of congenital anomaly in time 
and/or space which appears to be unusual”. This definition includes space as defined by a 
common activity such as a place of work/ education/ recreation etc. and not just space as 
defined by residence. Currently, the statistical monitoring at the Central Registry detects 
temporal clusters within each registry area while the space investigation is conducted by the 
registry at a local level.  
Currently, the JRC-EUROCAT Central Registry performs annual cluster analysis using the 
most recent five years of data. More than five years may tend to identify trends rather than 
clusters, and will be computationally slower. Less than five years may fail to detect if the 
most recent years are unusual compared to preceding years.  
Cluster detection is based on a moving window test; the method uses a moving window of a 
given number of cases (window size), measuring the length of time between the first and last 
case. It detects whether the given number of cases has occurred in a shorter time than would 
be expected by chance. The method is not robust with a window size of less than five cases, 
hence a minimum of seven cases over the study period of interest is needed to run the 
analysis. All window sizes from a minimum of five to a maximum of the total number of 
cases minus 2 are tested. Each registry and anomaly subgroup is tested independently.   
Many clusters may overlap in time, the inclusion or exclusion of individual cases changing 
their significance. In a first step, all significant clusters are identified. Then, the “most 
significant” cluster (lowest p-value) is selected. All other significant clusters (p<0.05) for 
which at least 75% of cases overlap with the “most significant” cluster are considered to 
belong to the same cluster group.  
Since the exposure during early pregnancy (i.e. when organogenesis occurs) is pertinent, it is 
preferable to use the estimated date of conception rather than the date of birth. Cluster 
detection uses date of conception where gestational age is recorded for more than 90% of 
cases (for any one anomaly subgroup and registry) allowing its estimation.  
Where gestational age is missing, it is estimated on the basis of the average gestational age in 
the registry, by year, anomaly subgroup, and outcome of pregnancy. Gestational age is not 
estimated if it is missing for more than 10% of cases for the registry and anomaly subgroup, 
in which case cluster detection is based on date of birth.  
Where date of conception is used as a basis for cluster detection, the conception period for 
statistical monitoring must end nine months before the last birth month where data 
collection is complete. The scan routine used here (see also Appendix C) includes cases with 
date of conception between 1st April 2013 and 31st March 2015 (24 months).  
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Central Registry produces a report of all clusters occurring in each registry. Every  registry 
then receives a report with its clusters for investigation. In the report, the clusters are visually 
identified over the time period. Each case is represented by an asterisk and the cluster 
identified by the segment under the timeline. These figures are also used in the present 
report. Registries are also provided with the ID codes that anonymise the cases included in 
each cluster. If the investigation of clusters identifies data errors (e.g. incorrect diagnoses, 
incorrect dates of birth) these errors should be corrected and updated data included in the 
next data transmission to the Central Registry. 
 
4.2 Cluster analysis 2011-2015 
Sixteen registries satisfied the criteria to be included in the cluster analysis reported here (see 
Appendix A). A total of 25 clusters were identified in nine registries (see Table 1).  
Reports on preliminary investigations were received from 8 out of 9 registries. The reports by 
registries into the 25 clusters detected in the monitoring indicated that 16 were not ‘true’ 
clusters as defined by EUROCAT, and were explained by data quality issues/changes in case 
ascertainment. No preliminary report was available for three clusters (see Table 1).  
For the following six clusters, the excess of cases was not explained, the significance was 
uncertain and future monitoring at the registry level is recommended: Ebstein’s anomaly 
(Emilia Romagna), Hypoplastic right heart (Isle de Reunion), Congenital cataract (Tuscany), 
VSD (Tuscany), Hypospadias (Tuscany), Skeletal dysplasia (Wales).  
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4.3 Preliminary investigations of specific clusters by registries 
Ebstein’s anomaly 
The cluster was detected in Emilia Romagna, Italy. It was a small cluster of five cases. As the 
number of total reported cases is very stable in recent years and high quality multisource 
ascertainment is in place for this anomaly, the registry considers this a chance occurrence. 
This cluster will be followed.  
 
Hypoplastic right heart  
The cluster was detected in Isle de Reunion. It is a small cluster, to be followed to verify if 
this is a ‘true’ cluster or a random fluctuation of cases. 
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Congenital cataract (Tuscany),  
A cluster of congenital cataract was detected in Tuscany, Italy. The 14 cases in the cluster 
were all isolated cases with confirmed diagnosis. There were no changes in the diagnostic or 
reporting practice. Since the prevalence of the anomaly observed in the last period in 
Tuscany is similar to the EUROCAT average, the registry does not consider the need for 
immediate action. The anomaly will be monitored at the local level.  
  
 
 
Ventricular Septal Defect (VSD) 
The cluster was detected in Tuscany, Italy. Five cases born on the same day were included in 
the cluster. All were isolated cases, distributed throughout the region. There were no 
changes in the diagnostic or reporting practice. Since the prevalence of the anomaly observed 
in the last period in Tuscany is similar to the EUROCAT average, the registry does not 
consider the need for immediate action. The registry concluded that these cluster requires 
follow-up of the cases to confirm the diagnosis and the surgery performed.  
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Hypospadias   
A cluster of hypospadias cases was detected in Tuscany. Out of the six cases in the cluster 
(duration four days) four were isolated cases, and two cases were from a twin pregnancy. 
There were no changes in the diagnostic or reporting practice. The registry does not consider 
the need for immediate action. The anomaly will be monitored at the local level.  
  
Skeletal dysplasias 
The cluster was detected in Wales. Skeletal dysplasias are a very heterogeneous group of 
conditions (many of which are genetic). This appears to be a cluster in time but the 
heterogeneous diagnoses and geography suggest it is more apparent than real, and it is 
difficult to judge if the cluster merits further investigation. However, the numbers involved 
in this time frame are very unusual and the registry will follow the cluster in next year’s 
analysis.  
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4.4 Clusters that were considered being not ‘true’ clusters after 
registries’ investigations 
 
Arhinencephaly / holoprosencephaly 
The cluster was detected in South West England. The cluster disappeared after removing a 
genetic case. It is not considered a ‘true’ cluster.  
 
 
 
Anophtalmos / Microphtalmos 
The cluster was detected in Wales. All cases in the cluster were geographically separated. 
There were only five cases in the cluster and taking into account the timeline, three cases in 
this  time period would not be unusual.  The cluster is considered small and will not be 
further investigated.  
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Congenital cataract 
The single cluster across one year identified in the Northern England registry appears to be 
due to the increased ascertainment of eye anomalies following a new source of notification. 
The expectation is that congenital cataracts will continue to be reported at this higher rate in 
the next year’s data.  
 
 
 
Atrial Septal Defect (ASD) 
The cluster was detected in South West England. When errors in dates of conception were 
corrected, a cluster was no longer detected. The registry concluded that this is not a ’true’ 
cluster. 
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PDA as only CHD in term infants 
The cluster was detected in Thames Valley, England. The gestational age for some of the 
cases in the cluster had been incorrectly reported and hence these were not cases of PDA in 
term infants. Once these cases were removed, a cluster was no longer detected.  
 
 
Hirschsprung’s Disease 
The cluster was detected in Thames Valley, England. The transition from the CAROBB 
(Congenital Anomaly Register for Oxfordshire, Berkshire and Buckinghamshire) into the 
NCARDRS1 is thought to have affected the reporting of this anomaly. This was not judged a 
`true’ cluster.  
 
                                           
1 Public Health England (PHE) has expanded congenital anomaly and rare disease registration to cover the whole population of 
England. The National Congenital Anomaly and Rare Disease Registration Service (NCARDRS) records congenital 
anomalies and rare diseases cases across England. The geographical areas previously covered by the regional  congenital 
anomalies registries in England are now covered by  NCARDRS.  
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Diaphragmatic hernia 
The cluster was detected in Cork and Kerry, Ireland. The report on this cluster investigation 
was not provided. 
 
 
Congenital hydronephrosis 
A cluster of congenital hydronephrosis was detected in Northern Netherlands. The registry 
reported that the majority of cases in the cluster are ‘minor anomalies’ that were sent to the 
Central Registry with the text “Hydronephrosis (due to UPJ stenosis)”. A congenital 
hydronephrosis is only considered a major anomaly if the diameter is greater than 10 mm; 
cases with a diameter >10 mm are a minority in the registry's database. Congenital 
hydronephrosis is detected in ultrasound screening which occurs more frequently now and 
therefore it is reported more nowadays. This is not a ’true’ cluster. 
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Hypospadias 
Clusters of hypospadias were detected in Northern England and South West England.  
In Northern England, isolated cases of hypospadias have only been recorded since 2013. This 
has given rise to a marked increase in the prevalence rate from 2013 onwards. Therefore, this 
is not a ‘true’ cluster. 
 
In South West England, the cluster was not detected once errors in dates of conception were 
corrected. South West England concluded that this is not a ‘true’ cluster.  
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Polydactyly 
The cluster was detected in Thames Valley, UK and Isle de Reunion, France.  
In the Thames Valley registry, the notification of orthopaedic anomalies was reduced during 
the transition to NCARDRS. Only six cases were recorded in 2015 compared with 22 in 2014.  
Thames Valley reported that this is probably not a ‘true’ cluster. 
 
 
Regarding the cluster detected in the Isle de Reunion registry, the registry reported that  it 
had added information from the consultation of infant surgery planning to their information 
sources from 2013. Also, hospital coding has improved for this anomaly. Before 2013, the 
cases were probably underestimated. The registry will follow closely this anomaly to 
understand if the increase is due to better ascertainment or as a result of other factor(s) 
(hereditary, high level of population of African origin, etc.).  
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Club Foot 
Clusters of club foot were detected in South West England and Northern England.  
Northern England reported that the change in registering club foot is highly likely to have 
contributed to the detection of clusters and to the increased prevalence of this anomaly in 
2014 and 2015. It is likely that clusters are artefacts and will not be detected in the context of 
5 years data at the increased prevalence level.  
 
 
Similarly, for South West England, there was an increase in cases reported in 2015. This is 
known to be due to a change in coding practice as result of standardisation within the new 
NCARDRS service, which resulted in more cases being coded/confirmed than was the 
previous practice within the South West Congenital Anomaly Register (SWCAR).  
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Hip dislocation and/or dysplasia 
The cluster was detected in Thames Valley and Cork and Kerry.  
Due to a problem with data quality during transition from CAROBB to NCARDRS, there 
was a marked drop in the notification of hip dysplasia in 2015. Only one case was recorded 
in 2015 compared with 61 in 2014. Thames Valley considers that this is not a ‘true’ cluster. 
 
The investigation report is not available for the cluster detected in Cork and Kerry. 
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Down syndrome 
Clusters of Down syndrome cases were detected in Emilia Romagna and Tuscany.  
In Emilia Romagna, the cluster was explained by quality issues: this cluster is a clear case of 
previous underreporting which the registry had identified, and also as a result of TOPFAs 
being reported late in the region.  
 
In Tuscany, the investigation was not performed because the cluster’s dimension is too large 
to be explored. 
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Klinefelter syndrome 
A cluster of Klinefelter syndrome was detected in South West England. The cluster included 
two cases from monozygotic twins. When they were evaluated as a single case, the cluster 
disappeared. This is not a ‘true’ cluster.  
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Table 1: Details of the 25 clusters detected in the 2011-2015 monitoring and outcomes of local registry preliminary investigations. 
Anomaly Registry EUROCAT Classification of Explanation 
No of cases in 
cluster 
Expected 
cases 
Valid 
cases 
Length of cluster 
(days) 
P value 
Arhinencephaly / 
holoprosencephaly 
South West England (UK) 
Data quality issues found to explain cluster – 
cluster disappeared after exclusion of one genetic 
case  
6 0.7 21 51 0.025 
Anophtalmos / 
Microphtalmos 
Wales (UK) 
The number of cases in cluster is too small to 
warrant further investigation.  
5 0.47 19 37 0.029 
Congenital cataract 
North England (UK) 
Data reporting found to explain cluster: 
increased ascertainment due to a new data source  
8 2.14 11 355 0.025 
Tuscany (Italy) Excess of cases - to be followed 14 5.65 16 547 0.009 
Ventricular Septal 
Defect 
Tuscany (Italy) 
Excess of cases - to be followed 
5 0.35 540 ----- <0.001 
Atrial Septal Defect South West England (UK) Data quality issues found to explain cluster 8 1.16 62 28 0.037 
Ebstein’s anomaly Emilia Romagna (Italy) Excess of cases - to be followed 5 0.85 7 187 0.015 
Hypoplastic right heart  Isle de Reunion (France) Excess of cases - to be followed 5 1.11 7 245 0.038 
PDA as only CHD in 
term infants 
Thames Valley (UK) 
Data quality issues found to explain cluster 
6 0.82 13 114 0.018 
HirschsprungDisease Thames Valley (UK) Data quality issues found to explain cluster 13 4.62 20 421 0.033 
Diaphragmatic hernia Cork and Kerry (Ireland) 
No report 
 
7 1.12 10 173 <0.001 
Congenital 
hydronephrosis 
North Netherlands (NL) 
Data reporting found to explain cluster: most 
cases are minor anomalies, detected in US screening 
34 14.64 141 160 0.022 
Hypospadias 
North England (UK) 
Data reporting found to explain cluster: change 
in registering club food, reported as isolated anomaly 
from 2013. 
 
76 44.43 173 468 <0.001 
South West England (UK) Data quality issues found to explain cluster 236 177.66 550 500 0.011 
Tuscany (Italy) Excess of cases - to be followed 6 0.5 194 3 0.027 
Club Foot 
North England (UK) 
Data reporting found to explain cluster: change 
in registering club food, reported as isolated anomaly 
from 2014. 
22 7.99 62 199 0.017 
South West England (UK) 
Data quality issues found to explain cluster: 
changes in coding practice. 
 
66 26.73 123 336 <0.001 
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Anomaly Registry EUROCAT Classification of Explanation 
No of cases in 
cluster 
Expected 
cases 
Valid 
cases 
Length of cluster 
(days) 
P value 
Hip dislocation and/or 
dysplasia 
Thames Valley (UK) 
Data quality issues found to explain cluster 
53 21.7 141 280 <0.001 
Cork and Kerry (Ireland) No report 5 0.31 477 ----- <0.001 
Polydactyly 
Isle de Reunion (France) Data quality issues found to explain cluster 82 44.88 153 454 <0.001 
Thames Valley (UK) Data quality issues found to explain cluster 50 29.92 85 545 0.032 
Skeletal dysplasias Wales (UK) Excess of cases - to be followed 18 6.65 40 257 0.035 
Down syndrome 
Emilia Romagna (Italy) Data quality issues found to explain cluster: 
timing of data reporting 
41 16.95 346 75 0.009 
Tuscany (Italy) No report 140 98.5 291 542 0.013 
Klinefelter syndrome  South West England (UK) Data quality issues found to explain cluster – 
when monozygotic twin are evaluated as one case, 
the cluster disappears 
5 0.34 13 40 <0.001 
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Appendix A: EUROCAT full member registries inclusion list 
 
 Pan-Europe trends Cluster monitoring 
Included in 
analysis 
Investigation 
reports 
Included in 
analysis 
Investigation 
reports 
Austria, Styria No, as data transmission >1 year late 
Belgium, Antwerp  ― No data for 2015 
Belgium, Hainaut  ―  ― 
Croatia, Zagreb  x  ― 
Denmark, Odense Collaboration agreement not signed 
France, Auvergne No, as data transmission >1 year late 
France, Brittany No, as data for 4 years only 
France, French West Indies No, as data for 7 years only  ― 
France, Paris No, as data transmission >1 year late 
France, Reunion  x   
Germany, Mainz  ― No data for 2015 
Germany, Saxony Anhalt  x  ― 
Hungary Collaboration agreement not signed 
Ireland, Cork & Kerry  x  x 
Ireland, Dublin No, as data transmission >1 year late 
Ireland, South East  ― No data for 2015 
Italy, Emilia Romagna     
Italy, Tuscany  x   
Malta  ― No data for 2015 
Netherlands, Northern      
Norway No, as data transmission >1 year late 
Poland, Wielkopolska No, as data transmission >1 year late 
Portugal, South  x  ― 
Spain, Basque Country  ― No data for 2015 
Spain, Valencia Region  ― No data for 2015 
Switzerland, Vaud    ― 
Ukraine  ― No data for 2015 
UK, E Midlands & S Yorkshire No, as data transmission >1 year late 
UK, Northern England     
UK, South West England 
    
UK, Thames Valley     
UK, Wales  x   
UK, Wessex    ― 
 Investigation report received 
   X    No Investigation report received 
   ―   Investigation report not required as no pan-Europe trends or clusters detected in registry 
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Appendix B: Congenital anomaly subgroup inclusion list  
 
The EUROCAT congenital anomaly subgroups are defined in EUROCAT Guide 1.4, Chapter 
3.3 (http://www.eurocat-network.eu/content/Section%203.3-%2027_Oct2016.pdf), and are 
analysed in the following ways: 
 Prevalence by outcome of pregnancy, by registry and year. All cases and All cases 
excluding genetic conditions2 are included in the analysis and the results are 
published in the prevalence tables available on the EUROCAT website 
(http://www.eurocat-network.eu/accessprevalencedata/prevalencetables). It is 
possible to perform dynamic prevalence calculations for combined registries/years 
on the website. 
 Analysis of trends, all outcomes of pregnancy are jointly considered. Genetic 
conditions are excluded from the statistical monitoring of all other subgroups.   
 Detection of clusters, all outcomes of pregnancy are jointly considered. Genetic 
conditions are excluded from the statistical monitoring of all other subgroups.  
 
 
EUROCAT Subgroups 
Prevalence by pregnancy 
outcome, registry, year 
Included in 
monitoring of 
trends 
Included in 
monitoring of 
clusters 
All anomalies  NO NO 
All anomalies excluding 
genetic conditions 
  NO 
Nervous system   NO NO 
Neural Tube Defects    
Anencephalus and similar    
Encephalocele    
Spina Bifida    
Hydrocephalus     
Severe microcephaly     
Arhinencephaly / 
holoprosencephaly  
   
Eye   NO NO 
Anophthalmos / 
microphthalmos   
   
Anophthalmos    
Congenital cataract     
Congenital glaucoma     
Ear, face and neck   NO NO 
                                           
2 Genetic syndromes/ microdeletions, skeletal dysplasias chromosomal anomalies 
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EUROCAT Subgroups 
Prevalence by pregnancy 
outcome, registry, year 
Included in 
monitoring of 
trends 
Included in 
monitoring of 
clusters 
 Anotia     
Congenital heart defects 
(CHD)  
  NO 
Severe CHD    
Common arterial truncus     
Double outlet right ventricle     
Transposition of great vessels     
Single ventricle     
VSD     
ASD     
AVSD     
Tetralogy of Fallot    
Tricuspid atresia and stenosis     
Ebstein's anomaly     
Pulmonary valve stenosis     
Pulmonary valve atresia     
Aortic valve atresia/stenosis    
Mitral valve anomalies    
Hypoplastic left heart     
Hypoplastic right heart     
Coarctation of aorta     
Aortic atresia/interrupted aortic 
arch 
   
Total anomalous pulm venous 
return  
   
PDA as only CHD in term infants 
(GA 37+ weeks) 
   
Respiratory  NO NO 
Choanal atresia     
Cystic adenomatous malf of 
lung  
   
Oro-facial clefts   NO NO 
Cleft lip with or without cleft 
palate  
   
Cleft palate     
Digestive system  NO NO 
Oesophageal atresia with or 
without tracheo-oesophageal 
fistula 
   
Duodenal atresia or stenosis     
Atresia or stenosis of other parts 
of small intestine 
   
Ano-rectal atresia and stenosis     
Hirschsprung's disease     
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EUROCAT Subgroups 
Prevalence by pregnancy 
outcome, registry, year 
Included in 
monitoring of 
trends 
Included in 
monitoring of 
clusters 
Atresia of bile ducts     
Annular pancreas     
Diaphragmatic hernia     
Abdominal wall defects   NO NO 
Gastroschisis    NO  
Omphalocele     
Urinary   NO NO 
Bilateral renal agenesis including 
Potter syndrome 
   
Multicystic renal  
dysplasia  
   
Congenital hydronephrosis     
Bladder exstrophy and/or 
epispadia  
   
Posterior urethral valve and/or 
prune belly 
   
Genital  NO NO 
Hypospadias     
Indeterminate sex     
Limb   NO NO 
Limb reduction     
Club foot - talipes equinovarus     
Hip dislocation and/or dysplasia    
Polydactyly     
Syndactyly     
Other anomalies/ 
syndromes 
   
Skeletal dysplasias    
Craniosynostosis     
Congenital constriction 
bands/amniotic band 
   
Situs inversus     
Conjoined twins     
Congenital skin disorders    
VATER/VACTERL    
Vascular disruption anomalies     
Laterality anomalies     
Teratogenic syndromes with 
malformations 
  NO 
Fetal alcohol syndrome     
Valproate syndrome     
Maternal infections resulting in 
malformations 
   
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EUROCAT Subgroups 
Prevalence by pregnancy 
outcome, registry, year 
Included in 
monitoring of 
trends 
Included in 
monitoring of 
clusters 
Genetic syndromes + 
microdeletions 
  NO 
Chromosomal   NO 
Down syndrome     
Patau syndrome/trisomy 13     
Edward syndrome/trisomy 18     
Turner syndrome     
Klinefelter syndrome     
Down syndrome Adjusted NO  NO 
Patau syndrome Adjusted NO  NO 
Edward syndrome Adjusted NO  NO 
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Appendix C: Summary of statistical methods  
 
Trends 
The pan-Europe monitoring can only be conducted centrally as it uses data from all the 
registries combined.  The methodology used for pan-Europe monitoring is the same as for 
the ten year trend monitoring (Box 1) with the exception that it is run using the last 10 years 
of data (2006-2015) or using nine years of data within the 10 year period (2006-2015) and  
adjusts for the effect of registry by fitting a multi-level Poisson regression model.   
Statistical methods: 
1. A chi square test for trend and for non-linear change based on number of cases and 
number of births per year is performed. 
2. Ten year trend tests are run using eight or 10 years of data within the 10 year period 
(2006-2015).   
3. Trend analysis is presented by individual year unless there are too few cases, when data 
is then grouped by two year intervals.  
4. Trend analysis is always based on year of birth/delivery. 
5. A trend test is performed if the average expected number of cases per two year interval 
is 5 or more, OR if the observed number of cases per two year interval is 2 or more 
6. Significant increasing or decreasing monotonic (going in one direction) trends are 
reported.  
 Where p<0.05 for trend component and p>0.01 for non-linear component, the results 
are identified as ‘increasing or decreasing trend‘ 
 Where p<0.05 for trend component and p<0.01 for non-linear component and the 
prevalence trend is monotonic, the results are identified as ‘increasing or decreasing 
trend ' 
 Where p<0.05 for trend component and p<0.01 for non-linear component and the 
prevalence trend is not monotonic, the results are identified as 'non-linear change' 
 Where p>0.05 for trend component and p<0.05 for non-linear component, the results 
are identified as 'non-linear change'.   
 Where p>0.05 for trend component and p>0.05 for non-linear component, the results 
are interpreted as showing no significant change over time.  
 The significance level (p-value) for both chi squared tests, direction (upward or 
downward) are given in the output. 
7. Trend analysis is conducted on 79 EUROCAT congenital anomaly subgroups and the 
following computer generated subgroups adjusted for maternal age and in utero 
survival: Down syndrome, Patau syndrome and Edward syndrome. 
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Clusters  
A ‘scan’ moving window method is used to detect clusters, (See EUROCAT Statistical 
Monitoring Protocol http://www.eurocat-network.eu/content/EUROCAT-Statistical-
Monitoring-Protocol-2012.pdf), scanning all recorded cases in the period 2011-2015. 
1. Clusters or deficits occurring in the last two years (2014-2015) that are less than 18 
months in length are reported.   
2. A minimum of seven cases over the surveillance period (2011-2015) is needed to run the 
scan analysis.  
3. The default scan analysis uses estimated date of conception, if date of conception is 
cannot be estimated for > 10% of cases, then cluster analysis uses date of birth.  
4. When date of conception is used as a basis for cluster detection, the period of 
surveillance ENDS with dates of conception on 31 March in the last year under 
surveillance (2015).  If date of birth/delivery is used to detect clusters, the last full year 
(1 January – 31 December) is included in the surveillance.   
5. The output of cluster analyses lists all significant clusters which may be over-lapping.  
All the output data should be examined to determine the full time period over which the 
excess number of cases is observed.  This may be outside the start and end date of the 
most significant cluster.  Cluster analysis is run on 75 EUROCAT subgroups of 
congenital anomalies (Appendix B). Seventeen major heterogeneous subgroups (e.g. 
nervous system, eye, congenital heart defects etc.) are excluded from analysis.   
6. Cluster test results are presented alongside 5-year trend (chi square) results, to help 
assess whether the cluster could be described as a short term trend. 
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Appendix D: Summary of registry preliminary 
investigation protocols for identified ten-year trends and 
clusters 
 
Investigation protocols and templates, provided to make the reporting process consistent 
between registries, are described in full in the EUROCAT Statistical Monitoring Protocol 
(http://www.eurocat-network.eu/content/EUROCAT-Statistical-Monitoring-Protocol-
2012.pdf). Using the templates, registries were asked to include the following in their 
investigation report:  
 
Ten-year trends: 
1. Are there changes in diagnosis, in reporting, in coding, or in population definition 
that explain the trend?  
2. Are there any known reasons why this might be a “real” trend in frequency of the 
anomaly? 
3. Will the investigation continue (if so, how? if not, why not?)? 
4. Which public health authority will the result be reported to? 
 
Investigations into significant increasing trends are classified as follows: 
A: Changes in case ascertainment (data quality)  
B: Changes in local or central registry methods e.g. definitions and inclusion criteria  
C: Changes in diagnostic methods  
D: Trend confirmed, due to known demographic changes  
E: Trend confirmed, investigation on-going 
F: Trend confirmed, further surveillance proposed before more detailed investigation  
G: Not real trend when additional years added, or heterogeneous subgroup  
H: No report or clear interpretation of preliminary investigations sent  
Some trends can be explained by a combination of the classification categories e.g. A/B.  The 
first classification category is considered the principal one, so trends classified as A/B are 
counted in the A category. 
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Clusters: 
1. The methods and results of investigations as to whether changes in diagnostic 
methods, training, personnel or reporting practice contributed to the cluster.  
2. The methods and results of any investigation into aetiological factors, including 
which aetiological factors were investigated and which source of information was 
used (registry database, further access to medical records or parents etc.). 
3. Any local concerns about exposures and how they came to your attention. 
4. Whether anyone in your region (e.g. local community or health professional) had 
previously been aware of the cluster.  
5. The basis for your decisions to conduct the investigation in the way you did, and 
whether you will continue to investigate (if so, how?  if not, why not?). 
6. Which public health authorities have been or will be notified about the cluster? 
7. Registries are asked to conclude from their preliminary investigations if this is a ‘true 
cluster of concern or not’ 
 
Cluster investigations can be classified as follows: 
 Apparent cluster with cause for concern, further investigation on-going 
 Cluster associated with etiologic heterogeneity, changes in inclusion criteria, 
diagnosis, familial or twin recurrence  
 Excess of cases confirmed, but no further investigation proposed other than further 
surveillance  
 Increase in cases, due to increasing use of invasive prenatal diagnostic procedures or 
improvements in prenatal ultrasound detection rates  
 Data quality issues found to explain cluster  
 No report of preliminary investigations sent to Central Registry  
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Appendix E: Summary of significant ten-year 
increasing and decreasing trends detected in 
the pan-Europe analysis 2015 
 
 Annual % change 
Anomaly Subgroup Direction % 
change 
Lower 
CI 
Upper 
CI 
Hydrocephaly Decreasing -1.6 -3.1 0.0 
Severe microcephaly Decreasing -4.2 -6.5 -2.0 
Anophtalmos/microphtalmos Decreasing -5.3 -9.2 -1.5 
Ventricular septal defect Increasing 0.7 0.1 1.3 
Atrial septal defect Increasing 1.0 0.1 2.0 
Tricuspid atresia and stenosis Increasing 5.3 1.0 9.5 
Pulmonary valve stenosis Decreasing -3.5 -5.2 -1.9 
Hypoplastic right heart Increasing 6.8 1.8 11.9 
Hypoplastic left heart Decreasing -2.3 -4.5 -0.1 
PDA as only Decreasing -5.3 -7.5 -3.1 
Cleft lip with or without palate Decreasing -1.2 -2.4 0.0 
Cleft palate Decreasing -1.6 -3.0 -0.1 
Gastroschisis Decreasing -2.6 -4.6 -0.7 
Multicystic renal dysplasia Increasing 1.8 0.0 3.5 
Congenital hydronephrosis Increasing 2.8 1.7 3.8 
Hypospadias Decreasing -1.9 -2.7 -1.1 
Club foot - talipes equinovarus Increasing 3.4 2.3 4.5 
Syndactyly Decreasing -3.1 -4.9 -1.3 
Vascular disruption anomalies Decreasing -2.4 -3.7 -1.2 
Congenital constriction bands Decreasing -4.1 -8.3 0.0 
Conjoined twins Decreasing -9.4 -17.3 -1.4 
Laterality anomalies Increasing 2.7 0.1 5.2 
Valproate syndrome Decreasing -27.5 -43.9 -11.1 
Genetic syndromes and microdeletions Decreasing -1.8 -3.1 -0.5 
Klinefelter syndrome Decreasing -7.6 -11.2 -3.9 
Down Syndrome age adjusted Decreasing -0.9 -1.8 -0.1 
Note: *Significant non-linear change is not included in this table 
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